SYSTEMATIC ANALYSIS OF INJECTION-SITE PAIN CAUSED BY SUBCUTANEOUS ADMINISTRATION OF THE ADALIMUMAB BIOSIMILAR FKB327 VERSUS ADMINISTRATION OF THE ADALIMUMAB REFERENCE PRODUCT VIA DIFFERENT DELIVERY METHODS Alten, R., Genovese, M. C., Boyce, M., Yonemura, T., Ito, T., Kellner, H. BMJ PUBLISHING GROUP. 2019: 699

View details for DOI 10.1136/annrheumdis-2019-eular.1292

View details for Web of Science ID 000472207102118